Scott M T, Warner S L
Cancer Res. 1976 Apr;36(4):1335-8.
The effects of 14 weekly injections, s.c. or i.v., of "human equivalent" doses (5.25 mg/sq m) of Corynebacterium parvum (CP) in mice have been compared. Both s.c. and i.v. CP caused significant splenomegaly and antibody to CP, but stimulation was considerably greater after i.v. CP. Delayed hypersensitivity levels to CP were similar after s.c. and i.v. injection. T-cell competence, as judged by phytohemagglutinin reactivity and delayed hypersensitivity to sheep cells, was unimpaired after s.c. CP and augmented by i.v. CP. Activated peritoneal macrophages capable of nonspecifically inhibiting tumor growth in vitro were detected only after i.v. CP, and in vivo resistance to tumor cell challenge was greater after CP administered i.v. than s.c.
已对小鼠皮下或静脉注射14周“人等效剂量”(5.25毫克/平方米)短小棒状杆菌(CP)的效果进行了比较。皮下和静脉注射CP均导致显著的脾肿大和针对CP的抗体,但静脉注射CP后的刺激作用明显更强。皮下和静脉注射后对CP的迟发型超敏反应水平相似。通过植物血凝素反应性和对绵羊细胞的迟发型超敏反应判断,皮下注射CP后T细胞功能未受损害,而静脉注射CP则增强了T细胞功能。仅在静脉注射CP后检测到能够在体外非特异性抑制肿瘤生长的活化腹膜巨噬细胞,并且静脉注射CP后对肿瘤细胞攻击的体内抵抗力大于皮下注射。